Simian Virology

The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. The global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%

It gives an overview of nonhuman primate models of restoratively vital viral disease and also characteristic contaminations of nonhuman primates with human and animal viruses. This subject incorporates primate models of medicinally imperative viral diseases, for example, AIDS, theories on the beginnings of plague types of HIV, and viral illnesses brought on by non-simian infections in both wild and hostage primates.

  • Applications of viral vectors
  • Advances in antiviral vaccine development
  • Types of Vaccines
  • Vectors in Gene Therapy

Related Conference of Simian Virology

Simian Virology Conference Speakers